Two Sigma Investments’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
Two Sigma Investments's SMMT Position: Q3 2026 in Review
Two Sigma Investments increased its Summit Therapeutics (SMMT) stake by 224% in Q3 2026, buying an estimated $23.4M and bringing the position to 2,259,925 shares worth $38.2M. The position accounts for 0.03% of the portfolio, ranked #672.
Two Sigma Investments first reported a position in SMMT in Q4 2022 and has held it in 11 quarters since. 296 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- Two Sigma Investments held 2,259,925 shares of Summit Therapeutics worth $38.2M as of Q3 2026.
- Two Sigma Investments bought 1,563,211 Summit Therapeutics shares in Q3 2026, an estimated $23.4M.
- Summit Therapeutics made up 0.03% of Two Sigma Investments's portfolio in Q3 2026, its #672 holding.
- Two Sigma Investments first reported a position in Summit Therapeutics in Q4 2022 and has held it in 11 quarters since.
- 296 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.